Nov 12
EMN · Eastman Chemical Co
$65.03
-0.58 (-0.88%)
At close · Nov 13
Return incl. dividend (before tax)
Market Cap
$7.44B
Shares
114.38M
Volume · Nov 13
1.07M
Avg daily vol (3M)
1.24M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$65.03
Open$65.70
Day$64.19–65.71
52W close$56.37–81.36
Avg vol 30d1.4M
Short int5.5M · 4.8% of shares · 3.6d
Short vol43%
Last earningsOct 30, 2026
DataJan 2020–Nov 2026
Filing10-Q · Oct 30
Up next
Jan 29, 2027
Est · unconfirmed
· in 11 wks
Latest documents
2026
Oct 30
Quarterly report
10-Q
FY2026 Q3, ended Sep 30
Third-quarter sales rise 8%, adjusted EPS reaches $1.84
Eastman reported third-quarter 2026 sales of $2,385 million, up 8%, and adjusted diluted EPS of $1.84, versus $1.14 in third quarter 2025. First-nine-month 2026 sales reached $7,075 million, while operating cash flow was $377 million versus $468 million in 2025.
Revenue $2.39B
▲ 8.3%
Net income $252M
▲ 265.2%
Diluted EPS $2.19
▲ 265.0%
Oct 30
Earnings call
Cash flow outlook cut to $850 million
Eastman lowered its full-year operating cash flow expectation from $900 to $850 million as Iran conflict inflation increased working-capital pressure, while expecting a Q4 release from nearly $500 million accumulated year to date.
Oct 29
Current report
8-K
Financial results
Eastman Chemical Company reported third-quarter 2026 sales revenue of $2,385 and diluted EPS of 2.19, and projects full-year adjusted diluted EPS of $6.00 to $6.20 with operating cash flow of approximately $850 million.
Oct 20
Current report
8-K
Events of Oct 16
Charter or bylaw amendment, or fiscal year change, Other events
Eastman Chemical Company adopted amended and restated bylaws on October 16, 2026, revising stockholder procedures, nomination windows, proxy access, and plurality voting. Notice periods for 2027 Annual Meeting are January 7, 2027-February 6, 2027 and October 25, 2026-November 24, 2026.
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$9.05B
Trailing 12 months
Net income (TTM)
$625.00M
Trailing 12 months
Revenue growth YoY
+8.3%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
12.0
Trailing earnings · reciprocal yield 8.4%
FCF yield
6.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$4.45B
Latest balance sheet
Dividend yield
5.2%
Trailing 12 months
Shares change YoY
-0.1%
Year over year · fewer shares
Price change (1Y)
+3.7%
Trailing year
Short interest
4.8%
Latest settlement · 3.6 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Jul 31, 2026
Q2 FY26
TL;DR. Eastman delivered a 10% YoY sales increase to $2,513M with adjusted EPS of $1.97 in Q2, driven by strong Chemical Intermediates spread/volume and specialty price-cost gains, while management raised its 2026 earnings outlook but lowered full-year operating cash flow guidance to ~$900M (from approaching 2025 levels) due to receivables pressure and now expects Q3 adjusted EPS to approach Q2's $1.97.
Bullish
- + Q2 sales rose 10% YoY to $2,513M with adjusted EPS of $1.97 vs. $1.60, aided by 350 bps sequential adjusted EBIT margin expansion.
- + Management raised its 2026 earnings outlook, stating results are 'better than where we were in April' with confidence in very strong earnings growth.
- + Chemical Intermediates sales surged 39% YoY (24% volume/mix, 14% price) with segment EBIT swinging from a $30M loss to $58M on spread expansion.
- + Kingsport methanolysis circular platform doubled revenue in H1 to over $100M and remains on track for $200M EBITDA potential.
- + Acetate tow volumes set to rise materially in H2 as customers increase purchases to meet annual minimum volume commitments, providing a Fibers tailwind.
Bearish
- − Full-year 2026 operating cash flow guidance was lowered to ~$900M (modestly below 2025 levels) as ~$370M H1 receivables build from pricing actions pressures working capital.
- − Fibers sales fell 11% YoY (-10% volume/mix) on acetate tow destocking and textile weakness, with segment H1 EBIT down to $81M from $169M.
- − Texas methanolysis expansion capital spending pushed out until 2028 due to higher capital costs and loss of DOE grant, delaying capacity growth.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 19.3 · elevated
Equity put/call 0.63
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−1%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
35%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−13%
trailing
YTD return
+2%
this year
Relative strength
−13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $66 › 200d $71 — 200d above 50d
Institutional flow
Accumulating
606 of 656 funds reported for Sep 30 · net +858.6K sh shares · +69 new
Insider flow
Accumulating
Net +$160.0K over 90 days · 0% sells
Short interest
Falling
4.84% of shares out · ▼ -11.4% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
656 holders — near 3-yr low, contrarian setup
Squeeze score
58
elevated · 0–100
Fundamentals
Revenue growth
−7%
Y/Y
Gross margin
21%
contracting
EPS growth
−47%
Y/Y
Free cash flow
$424.0M
Valuation
P/E 12
below peers
Buyback
$1.3B
remaining
Balance sheet
$4.2B
net debt
Quant / Vol
risk profile
Volatility
32%
annualized · 1-yr
Max drawdown
−24%
past year
ATR
2.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Oct 29, 2026
2026
Selling price increases
$500M
full-year 2026
Adjusted earnings per share
Non-GAAP
$6.00 – $6.20
Operating cash flow
Lowered
$850M
Jul 30, 2026
$900M
changed to
Oct 29, 2026
$850M
Forecasted full year
Forecasted full year adjusted effective tax rate
Non-GAAP
15%
Previous outlook
earlier release
· from the Earnings Call filed Jul 31, 2026
Still-open targets the latest release did not restate under the same label.
Performance films earnings
· Q1 next year in 2027
$25M – $30M
Revenue
· this year
$500M
Sales
· this year
at least $100M
EBITDA
· long-term
$200M
Utilization
· as demand growth comes
up to 100%
Design capacity
· targeted incremental capital projects
up to 130%
Prior guidance
period ended
· from the 8-K filed Jul 30, 2026
Third-quarter adjusted EPS
· third-quarter 2026
$1.97
Guided vs delivered
· last 1 settled
EPS
2022
guided $9.50 – $10.00
$6.35
Miss −34.9%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
35%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $66 › 200d $71 — 200d above 50d
Institutional flow
Accumulating
606 of 656 funds reported for Sep 30 · net +858.6K sh shares · +69 new
Insider flow
Accumulating
Net +$160.0K over 90 days · 0% sells
Short interest
Falling
4.84% of shares out · ▼ -11.4% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
656 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $56
Now $65 · 35%
Range high $81
vs 200-day avg -8%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Total amounts sold under the accounts receivable factoring program | $647M | FY2026 Q3 | -7.0% |
|
|
|||
| Adjusted EBIT (Additives & Functional Products) non-GAAP | $151M | Second Quarter 2026 filing | — |
| Adjusted EBIT (Advanced Materials) non-GAAP | $109M | Second Quarter 2026 filing | — |
| Adjusted EBIT (Chemical Intermediates) non-GAAP | $58M | Second Quarter 2026 filing | — |
| Adjusted EBIT (Fibers) non-GAAP | $36M | Second Quarter 2026 filing | — |
| Cash dividends declared per share | $0.84 | second quarter 2026 filing | — |
| Loss before interest and taxes excluding non-core items non-GAAP | -$34M | the second quarter 2026 filing | — |
| Other (income) charges, net excluding non-core items non-GAAP | $6M | the second quarter 2026 filing | — |
| Adjusted EBIT (Total Operating Segments) non-GAAP | $592M | First Six Months | — |
|
|
|||
| Adjusted EBIT Margin (Total Operating Segments) non-GAAP | 12.6% | First Six Months | — |
|
|
|||
| Adjusted effective tax rate non-GAAP | 15% | First Six Months | — |
| Adjusted net earnings attributable to Eastman non-GAAP | $352M | First Six Months | — |
| Adjusted net earnings attributable to Eastman per diluted share non-GAAP | $3.06 | First Six Months | — |
| Loss before interest and taxes excluding non-core items (Other) non-GAAP | -$34M | Second Quarter | — |
|
|
|||
| Total earnings before interest and taxes excluding non-core items non-GAAP | $520M | First Six Months | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EMN
this stock
Eastman Chemical Co
|
$7.44B | +1.9% | -6.7% | 12.0 | 4.8% |
|
LIN
Linde PLC
|
$241.51B | +23.4% | +3.0% | 34.9 | 1.4% |
|
AIQUF
L Air Liquide SA
|
$137.11B | +14.4% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$86.74B | +17.8% | +2.2% | 42.1 | 1.5% |
|
SHW
Sherwin Williams Co
|
$84.53B | +8.0% | +2.1% | 32.2 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EMN | +1.0% | +4.3% | -12.6% | -2.3% | +1.9% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -1.6% | +5.5% | -13.1% | -2.1% | -8.7% |
Capital returns
Latest dividend
$0.84
/ share · ex Sep 15, 2026
Paid (TTM)
$3.36
/ share · 4 payouts
Dividend yield (TTM, derived)
5.17%
Buyback program
· as of Sep 30, 2026
Authorized
$2.50B
Spent (derived)
$1.20B
Remaining
$1.30B
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
915389
CUSIP
277432100
13F (30d)
563 filings
491 filers
Visit website
Investor relations